| Publication Date | Title | Author(s) |
| Jan-2015 | Citizen Brief: Addressing Nutritional Risk Among Older Adults in Ontario | Gauvin, François-Pierre; Lavis, JN; Bhuiya, AR; Mahendren, Mathura |
| Jan-2020 | Citizen brief: Supporting rapid learning and improvement for select conditions in Canada | Bhuiya, AR; Moat, KA; Lavis, JN |
| Jan-2021 | COVID-19 living evidence profile #1 (version 1.2): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Feb-2021 | COVID-19 living evidence profile #1 (version 1.3): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Feb-2021 | COVID-19 living evidence profile #1 (version 1.4): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Mar-2021 | COVID-19 living evidence profile #1 (version 1.5): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Apr-2021 | COVID-19 living evidence profile #1 (version 1.6): What is known about anticipated COVID-19 vaccine roll-out elements? | Bhuiya, AR; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Rintjema, J; Sharma, K; Santesso, N; Lavis, JN; Wilson, MG |
| May-2021 | COVID-19 living evidence profile #1 (version 1.7): What is known about anticipated COVID-19 vaccine roll-out elements? | Bhuiya, AR; Bain, T; Wang, Q; Al-Khateeb, S; DeMaio, P; Ahmad, A; Drakos, A; Rintjema, J; Sharma, K; Matthews, M; Gauvin, François-Pierre; Lavis, JN; Wilson, MG |
| Oct-2021 | COVID-19 living evidence profile #2 (version 2.5): What is known about supporting renewal in long-term care homes? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Lavis, JN |
| May-2021 | COVID-19 living evidence profile #3 (version 3.1): What is known about how schools (K-12) and postsecondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase? | Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; Rintjema, J; DeMaio, P; Alam, S; Gauvin, François-Pierre; Santesso, N; Lavis, JN; Wilson, MG |
| Jun-2021 | COVID-19 living evidence profile #3 (version 3.2): What is known about how schools (K-12) and postsecondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase? | Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; DeMaio, P; Rintjema, J; Abeer, A; Gauvin, François-Pierre; Matthews, M; Lavis, JN; Wilson, MG |
| Sep-2021 | COVID-19 living evidence profile #3 (version 3.3): What is known about how schools (K-12) and post-secondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase? | Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; Rintjema, J; DeMaio, P; Matthews, M; Lavis, JN; Wilson, MG |
| May-2021 | COVID-19 living evidence profile #4 (version 4.1): What went well and what could have gone better in the COVID-19 response in Canada, as well as what will need to go well in future given any available foresight work being conducted? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Sharma, K; DeMaio, P; Lavis, JN |
| Jun-2021 | COVID-19 living evidence profile #4 (version 4.2): What went well and what could have gone better in the COVID-19 response in Canada, as well as what will need to go well in future given any available foresight work being conducted? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Sharma, K; DeMaio, P; Lavis, JN |
| Jul-2021 | COVID-19 living evidence profile #4 (version 4.3): What went well and what could have gone better in the COVID-19 responses, as well as what will need to go well in future given any available foresight work being conducted? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Sharma, K; DeMaio, P; Lavis, JN |
| Aug-2021 | COVID-19 living evidence profile #4 (version 4.4): What went well and what could have gone better in the COVID-19 responses, as well as what will need to go well in future given any available foresight work being conducted? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Sharma, K; DeMaio, P; Lavis, JN |
| Jun-2021 | COVID-19 living evidence profile #5 (version 5.1): What went well and what could have gone better in the COVID-19 response in other countries, as well as what will need to go well in future given any available foresight work being conducted? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Sharma, K; DeMaio, P; Lavis, JN |
| Jul-2021 | COVID-19 living evidence profile #5 (version 5.2): What went well and what could have gone better in the COVID-19 response in other countries, as well as what will need to go well in future given any available foresight work being conducted? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Sharma, K; DeMaio, P; Bierman, O; Lavis, JN |
| Aug-2021 | COVID-19 living evidence profile #5 (version 5.3): What went well and what could have gone better in the COVID-19 response in other countries, as well as what will need to go well in future given any available foresight work being conducted? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Sharma, K; DeMaio, P; Biermann, O; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #11: What is the evidence related to playground equipment and risk of COVID-19 transmission? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Sharma, K; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #12: What insights from the available evidence and jurisdictional scans can inform who should be tested for COVID-19 and how frequently, where, by whom and with what follow-up actions should they be tested? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #13: What pandemic-related mental health and addictions issues have emerged and what indicators and strategies can be used to monitor and address them, respectively? | Waddell, K; Wilson, MG; Bullock, HL; Evans, C; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #14: Where and with what impacts have shifts from in-person to virtual approaches occurred in the delivery of healthcare services in general and mental health and addictions services in particular? | Waddell, K; Bullock, HL; Evans, C; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Mansilla, C; Wang, Q; Bhuiya, AR; Ahmad, A; Filbey, L; Lavis, JN |
| Jul-2020 | COVID-19 rapid evidence profile #15: What frameworks from available evidence and experiences in other countries can inform what needs to be done to plan for future waves of COVID-19? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Bhuiya, AR; Voorheis, P; Ahmad, A; Gao, C; Alam, S; Lavis, JN |
| Jul-2020 | COVID-19 rapid evidence profile #16: What provider-led virtual-care services can be used to replace in-person care in hospital-based ambulatory care settings? | Wilson, MG; Waddell, K; Wang, Q; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Ahmad, A; Alam, S; Bhuiya, AR; Lavis, JN |
| Aug-2020 | COVID-19 rapid evidence profile #17: What evidence could support modelling scenarios related to the reopening, operation and monitoring of schools? | Wilson, MG; Waddell, K; Moat, KA; Wang, Q; Ahmad, A; Alam, S; Bhuiya, AR; Sharma, K; Lavis, JN |
| Sep-2020 | COVID-19 rapid evidence profile #18: Which types of non-medical masks are effective in community settings for reducing the spread of COVID-19 for different populations and under different conditions? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Wang, Q; Ahmad, A; Bhuiya, AR |
| Sep-2020 | COVID-19 rapid evidence profile #19: What is the risk of transmission of COVID-19 in hospital and long-term care settings, and the impacts of hospital-visitor policies? | Waddell, K; Wilson, MG; Moat, KA; Wang, Q; Gauvin, François-Pierre; Ahmad, A; Alam, S; Bhuiya, AR; Tchakerian, N; Lavis, JN |
| Oct-2020 | COVID-19 rapid evidence profile #21: What is the impact of the pandemic on substance use (particularly, alcohol and opioid use) in the population, and what policy decisions have been adopted that affect the availability and use of substances, as well as services for people who use substances? | Bullock, H; Waddell, K; Bhuiya, AR; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Alam, S; Lavis, JN |
| Oct-2020 | COVID-19 rapid evidence profile #22: What is known about whether vaccine injury-compensation programs and program elements affect vaccine acceptance and uptake? | Bhuiya, AR; Waddell, K; Moat, KA; Wilson, MG; Gauvin, François-Pierre; Whitelaw, S; Alam, S; Sharma, K; Drakos, A; Lavis, JN |
| Nov-2020 | COVID-19 rapid evidence profile #23: What is known about anticipated COVID-19 vaccine-delivery program elements, and whether and how federated states are harmonizing these elements across constituent units of federations? | Bhuiya, AR; Wilson, MG; Moat, KA; Gauvin, François-Pierre; Wang, Q; Whitelaw, S; Alam, S; Sharma, K; Ahmad, A; Drakos, A; Dren, N; Bain, T; Lavis, JN |
| Jan-2021 | COVID-19 rapid evidence profile #25: What do we know from both research and jurisdictional scans about prioritizing vaccination of asymptomatic residents in a long-term care home with an outbreak? | Wang, Q; Wilson, MG; Alam, S; Ahmad, A; Bain, T; Bhuiya, AR; Drakos, A; Sharma, K; Whitelaw, S; Bain, T; Lavis, JN |
| Mar-2021 | COVID-19 rapid evidence profile #26: When and in what order can COVID-19-related public-health measures be lifted (or stringency be reduced) as vaccination rates and seasonal temperatures increase? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Jan-2022 | COVID-19 rapid evidence profile #27: What measures and approaches can protect the most vulnerable in hospitals when outbreaks of Omicron in hospital are becoming more common? | Wilson, MG; Bhuiya, AR; Bain, T; Al-Khateeb, S; Mansilla, C; Mehta, V; Sood, T; Soueidan, S; Rintjema, J; Waddell, K; Wang, A; Wang, Q; Wang, X; Lavis, JN |
| Jan-2022 | COVID-19 rapid evidence profile #28: What is the filtration performance of KN95 masks compared to surgical and N95 masks, and how can their use be optimized in hospital settings? | Al-Khateeb, S; Bain, T; Bhuiya, AR; Mansilla, C; Mehta, V; Sood, T; Wang, Q; Soueidan, S; Rintjema, J; Wang, A; Lavis, JN; Wilson, MG |
| Dec-2020 | Dialogue summary: Creating a pan-Canadian learning health system for neurodevelopmental disorders | Bhuiya, AR; Moat, KA |
| Mar-2024 | Dialogue summary: Creating an integrated innovation system to enable the adaptation and uptake of health-system innovations in Canada | Bhuiya, AR; Cura, J; Wilson, MG |
| Feb-2020 | Dialogue summary: Supporting rapid learning and improvement for select conditions in Canada | Moat, KA; Bhuiya, AR; Voorheis, P |
| Mar-2024 | Evidence brief: Creating an integrated innovation system to enable the adaptation and uptake of health-system innovations in Canada | Wilson, MG; Bhuiya, AR; DeMaio, P; Gauvin, François-Pierre; Moat, KA; Cura, J; Lavis, JN |
| Feb-2020 | Evidence brief: Supporting rapid learning and improvement for select conditions in Canada | Moat, KA; Bhuiya, AR; Waddell, K; Lavis, JN |
| Jun-2023 | Evidence brief: Supporting the evidence-based use of cannabis for chronic pain in Canada | Moat, KA; Bain, T; Bhuiya, AR; DeMaio, P; Alam, S; Lavis, JN |
| May-2022 | Living evidence profile #6.1: What is the best-available evidence related to the monkeypox outbreak? Hamilton: McMaster Health Forum, 27 May 2022 | Wilson, MG; Bhuiya, AR; Bain, T; DeMaio, P; Al-Khateeb, S; Sharma, K; Alam, S; Mehta, V; Soueidan, S; Velez, CM; Loeb, M; Lavis, JN |
| May-2024 | Living evidence profile #8.2: Identifying features and impacts of public health strategies that can be used to prevent, reduce, and/or mitigate avian influenza spillover to humans | Bain, T; Bhuiya, AR; Waddell, K; DeMaio, P; Alam, S; Wang, Q; Ciurea, P; Wu, N; Chen, K; Wilson, MG |
| Jul-2024 | Living evidence profile #8.3: Identifying features and impacts of public health strategies that can be used to prevent, reduce, and/or mitigate avian influenza spillover to humans | Bain, T; Bhuiya, AR; Waddell, K; Alam, S; DeMaio, P; Ali, A; Wu, N; Ciurea, P; Dass, R; Grewal, E; Shivji, A; Wilson, MG |
| Aug-2024 | Living evidence profile 6.12: Best-available evidence related to the mpox outbreak | Wu, N; Waddell, K; Bhuiya, AR; Bain, T; DeMaio, P; Grewal, E; Ali, A; Alam, S; Loeb, M; Wilson, MG |
| Jan-2024 | Living evidence profile 7.1: Examining what is known about the emergence, transmission and spectrum of the burden of disease of avian influenza A (H5Nx) subtypes | Bhuiya, AR; Bain, T; Dass, R; Chen, K; Wilson, MG |
| May-2024 | Living evidence profile 7.2: Examining what is known about the emergence, transmission and spectrum of the burden of disease of avian influenza A (H5Nx) subtypes | Bhuiya, AR; Bain, T; Waddell, K; Ali, A; DeMaio, P; Moat, K; Wilson, MG |
| May-2024 | Living evidence profile 7.3: Examining what is known about the emergence, transmission, and spectrum of the burden of disease of avian influenza A(H5Nx) subtypes | Bhuiya, AR; Bain, T; Alam, S; Ciurea, P; Chen, K; Velez, CM; Wu, N; Wang, Q; Waddell, K; DeMaio, P; Wilson, MG |
| Jul-2024 | Living evidence profile 7.4: Examining what is known about the emergence, transmission, and spectrum of the burden of disease of avian influenza A(H5Nx) subtypes | Bhuiya, AR; Bain, T; Ciurea, P; Alam, S; Grewal, E; Dass, R; Ali, A; Wu, N; Waddell, K; DeMaio, P; Wilson, MG |
| Jan-2020 | Panel summary: Supporting rapid learning and improvement for select conditions in Canada | Bhuiya, AR; Choi, C; Moat, KA |
| Sep-2022 | Profil de données probantes rapide 29.2 : Que pouvons-nous retenir des données probantes et des expériences d’autres administrations sur la prestation de soins palliatifs aux personnes en situation ou à risque d’itinérance? | Bhuiya, AR; Bain, T; Al-Khateeb, S; Soueidan, S; Wang, A; Jarvis, T; Sood, T; DeMaio, P; Mehta, V; Wilson, MG |
| Jan-2024 | Profil de données probantes rapide 64 : Déterminer les caractéristiques et les répercussions des stratégies de santé publique qui peuvent être utilisées pour prévenir, réduire ou atténuer les répercussions de la grippe aviaire sur les humains | Bain, T; Bhuiya, AR; DeMaio, P; Wilson, MG |
| Feb-2025 | Profil de données probantes vivantes #6.14: Meilleures données probantes disponibles relatives à l’éclosion de mpox | Bhuiya, AR; Dass, R; Cura, J; Sivanesanathan, T; Ali, A; Grewal, E; Loeb, M; Wilson, MG |
| Aug-2024 | Profil de preuves vivantes 6.12: Meilleures données probantes disponibles relatives à l’éclosion de mpox | Wu, N; Waddell, K; Bhuiya, AR; Bain, T; DeMaio, P; Grewal, E; Ali, A; Alam, S; Loeb, M; Wilson, MG |
| Jan-2024 | Profil de preuves vivantes 7.1 : Examen de ce que l’on sait au sujet de l’émergence, de la transmission et du spectre de la charge de morbidité des sous-types de la grippe aviaire A(H5Nx) | Bhuiya, AR; Bain, T; Dass, R; Chen, K; Wilson, MG |
| May-2024 | Profil de preuves vivantes 7.3 : Examen de ce qui est connu au sujet de l’émergence, de la transmission et du spectre du fardeau de la maladie des sous-types de l’influenza aviaire A(H5Nx) | Bhuiya, AR; Bain, T; Alam, S; Ciurea, P; Chen, K; Velez, CM; Wu, N; Wang, Q; Waddell, K; DeMaio, P; Wilson, MG |
| Jul-2024 | Profil de preuves vivantes 7.4 : Examen de ce qui est connu au sujet de l’émergence, de la transmission et du spectre du fardeau de la maladie des sous-types de l’influenza aviaire A(H5Nx) | Bhuiya, AR; Bain, T; Alam, S; Ciurea, P; Chen, K; Velez, CM; Wu, N; Wang, Q; Waddell, K; DeMaio, P; Wilson, MG |
| May-2024 | Profil de preuves vivantes 8.2 : Identifier les caractéristiques et les impacts des stratégies en matière de santé publique qui peuvent être utilisées pour prévenir, réduire et/ou minimiser les effets de l’influenza aviaire sur les humains | Bain, T; Bhuiya, AR; Waddell, K; DeMaio, P; Alam, S; Wang, Q; Ciurea, P; Wu, N; Chen, K; Wilson, MG |
| Jul-2024 | Profil de preuves vivantes 8.3 : Identifier les caractéristiques et les impacts des stratégies en matière de santé publique qui peuvent être utilisées pour prévenir, réduire et/ou minimiser les effets de l’influenza aviaire sur les humains | Bain, T; Bhuiya, AR; Waddell, K; DeMaio, P; Alam, S; Wang, Q; Ciurea, P; Wu, N; Chen, K; Wilson, MG |
| Jun-2024 | Profil rapide de données probantes #73: Efficacité des masques dans la réduction de l’exposition à la fumée des feux de végétation, aux épisodes de chaleur accompagnés de fumée des feux de végétation et autres polluants associés aux feux de végétation, ainsi que dans la réduction de leur impact sur la santé | Wu, N; Waddell, K; Ali, A; Bain, T; Bhuiya, AR; DeMaio, P; Grewal, E; Wilson, MG |
| Sep-2022 | Rapid evidence profile #29.2: What do we know from evidence and experiences from other jurisdictions about providing palliative care for those who are experiencing or at risk of homelessness? | Bhuiya, AR; Bain, T; Al-Khateeb, S; Soueidan, S; Wang, A; Jarvis, T; Sood, T; DeMaio, P; Mehta, V; Wilson, MG |
| Mar-2022 | Rapid evidence profile #29: What do we know from evidence and experiences from other jurisdictions about providing palliative care for those who are experiencing or at risk of homelessness? | Bhuiya, AR; Bain, T; Al-Khateeb, S; Soueidan, S; Wang, A; Jarvis, T; Sood, T; Mehta, V; Wilson, MG |
| Jul-2022 | Rapid evidence profile #31: What is the current readiness and capacity of Canadian public-health systems to address climate change, and how do they need to adjust their public-health functions and system features to do so? | Velez, CM; Waddell, K; Bain, T; Bhuiya, AR; Al-Khateeb, S; Alam, S; DeMaio, P; Mehta, V; Sharma, K; Soueidan, S; Lavis, JN; Wilson, MG |
| Aug-2022 | Rapid evidence profile #33: What is known from the evidence about optimizing out-of-hospital surgical capacity to reduce waitlists? | Waddell, K; Moat, KA; DeMaio, P; Alam, S; Sharma, K; Bhuiya, AR; Bain, T; Wilson, MG; Lavis, JN |
| Sep-2022 | Rapid evidence profile #34: What is known about physician mental wellness and physician-targeted mental-wellness initiatives in Canada? | Bain, T; Bhuiya, AR; Alam, S; Mehta, V; Tchakerian, N; Lavis, JN; Wilson, MG; Moat, KA |
| Aug-2022 | Rapid evidence profile #35: What is known from the evidence about the size and nature, impact and drivers of physician administrative load, as well as the approaches that can be adopted to manage physician administrative load? | DeMaio, P; Bain, T; Al-Khateeb, S; Bhuiya, AR; Alam, S; Sood, T; Mehta, V; Waddell, K; Moat, KA; Wilson, MG; Lavis, JN |
| Sep-2022 | Rapid evidence profile #36: What is known from the evidence and experiences about challenges of aging with dignity and options to support aging with dignity in the community? | DeMaio, P; Bain, T; Al-Khateeb, S; Bhuiya, AR; Alam, S; Soueidan, S; Wang, A; Khan, Z; El-Kadi, A; Evans, C; Wilson, MG; Lavis, JN |
| Jan-2023 | Rapid evidence profile #40: What is known about mental-wellness challenges facing Canadians and mental health system-transformation initiatives? | DeMaio, P; Bhuiya, AR; Al-Khateeb, S; Wang, A; Khan, Z; El-Kadi, A; Sharma, K; Tchakerian, N; Alam, S; Bain, T; Song, X; Lavis, JN; Wilson, MG; Moat, KA |
| Nov-2022 | Rapid evidence profile #41: What do we know from the best-available evidence and from the experiences of other jurisdictions about the functions that local-systems are responsible for and the ways in which they are held accountable for performing these functions? | Waddell, K; DeMaio, P; Bhuiya, AR; El-Kadi, A; Moat, KA; Lavis, JN |
| Dec-2022 | Rapid evidence profile #45: What is known from evidence and from experiences in other jurisdictions about how to effectively and efficiently improve wait times for scheduled (elective) surgical services? | Waddell, K; Alam, S; Bhuiya, AR; Bain, T; Wilson, MG |
| May-2023 | Rapid evidence profile #48: Implementing diabetes prevention and risk management programs | Waddell, K; Alam, S; Ali, A; Bhuiya, AR; Sharma, K; Wilson, MG |
| May-2023 | Rapid evidence profile #50: Impacts of private financing of health programs, services and products on equity-centred quadruple aim metrics | Waddell, K; Wilson, MG; Ali, A; Bain, T; Bhuiya, AR; Chen, K; Cura, J; DeMaio, P |
| Aug-2023 | Rapid evidence profile #52: Understanding the health-system context and evidence-support system assets for decision-making about the health and well-being of military personnel, Veterans and their families in the Five Eyes countries | Waddell, K; Wilson, MG; Bhuiya, AR; Bain, T; Alam, S; Sharma, K; Phelps, A; Chen, K; DeMaio, P; Ali, A; Kahn, Z; Lavis, JN |
| Jul-2023 | Rapid evidence profile #53: Examining the effectiveness of public health interventions to address wildfire smoke, combined heat-smoke events and pollutants | Waddell, K; DeMaio, P; Alam, S; Ali, A; Bain, T; Bhuiya, AR; Chen, K; Sharma, K; Wilson, MG |
| Aug-2023 | Rapid evidence profile #55: National and sub-national stewardship for improving healthy school communities and student health outcomes | Waddell, K; Alam, S; Ali, A; Bain, T; Bhuiya, AR; Cura, N; Dass, R; DeMaio, P; Phelps, A; Wilson, MG |
| Nov-2023 | Rapid evidence profile #56: Examining types of misinformation and disinformation and the effectiveness of interventions to combat misinformation and disinformation | Velez, CM; Waddell, K; DeMaio, P; Bhuiya, AR; Lavis, JN; Wilson, MG |
| Dec-2023 | Rapid evidence profile #58: Examining the use of serosurveillance approaches to monitor diseases and conditions and inform policy decisions | Bain, T; Bhuiya, AR; Dass, R; Alam, S; Phelps, A; Wilson, MG |
| Dec-2023 | Rapid evidence profile #60: Examining the features and impacts of incentive programs for return to work after a period of disability | Grewal, E; Bain, T; Waddell, K; Bhuiya, AR; Dass, R; Phelps, A; Alam, S; DeMaio, P; Ali, A; Chen, K; Wilson, MG |
| Dec-2023 | Rapid evidence profile #61: Examining the impact of worker engagement and participation in creating psychological health and safety at work | Grewal, E; Bain, T; Waddell, K; Bhuiya, AR; Dass, R; Phelps, A; Alam, S; DeMaio, P; Ali, A; Chen, K; Wilson, MG |
| Feb-2024 | Rapid evidence profile #62: Examining the effects of care models and program elements of repeat treatment approaches for substance use and concurrent mental health conditions | Waddell, K; Jaspal, A; DeMaio, P; Bhuiya, AR; Phelps, A; Wilson, MG |
| Jan-2024 | Rapid evidence profile #64: Identifying features and impacts of public health strategies that can be used to prevent, reduce and/or mitigate avian influenza spillover to humans | Bain, T; Bhuiya, AR; DeMaio, P; Wilson, MG |
| Jan-2024 | Rapid evidence profile #65: Mental health literacy and its role in national-level mental health strategies | DeMaio, P; Phelps, A; Bhuiya, AR; Gao, C; Alam, S; Dass, R; Wilson, MG |
| Feb-2024 | Rapid evidence profile #66: Exploring female-dominant conditions among military personnel and Veterans in each of the ‘Five Eyes’ countries | Waddell, K; Jaspal, A; Shivji, A; Ali, A; Bhuiya, AR; Wilson, MG |
| Feb-2024 | Rapid evidence profile #67: Identifying what is known about the health-system arrangements that can support the delivery of innovative models of home care | Bain, T; DeMaio, P; Ahmednur, A; Bhuiya, AR; Alam, S; Moat, KA |
| Mar-2024 | Rapid evidence profile #70: Strategies for enhancing public-health-focused data literacy | Bhuiya, AR; Jaspal, A; Grewal, E; Dass, R; Wilson, MG |
| May-2024 | Rapid evidence profile #71: Examining the association between noise exposure and delayed hearing loss | Waddell, K; Wu, N; DeMaio, P; Bain, T; Bhuiya, AR; Wilson, MG |
| Jun-2024 | Rapid evidence profile #72: Collecting information on dimensions of equity, diversity, and inclusion in electronic medical records (EMRs) | Waddell, K; Bhuiya, AR; Ali, A; Cuirea, P; Phelps, A; Chen, K; Grewal, E; Wilson, MG |
| Jun-2024 | Rapid evidence profile #73: Effectiveness of masks to reduce exposure and health impacts of wildfire smoke, combined heat-wildfire smoke events, and other pollutants associated with wildfires | Wu, N; Waddell, K; Ali, A; Bain, T; Bhuiya, AR; DeMaio, P; Grewal, E; Wilson, MG |
| Aug-2024 | Rapid evidence profile #77: Examining approaches to improve care transitions to long-term care facilities | Waddell, K; Chen, K; Dass, R; Bhuiya, AR; Saleh, R; Grewal, E; Jaspal, A; Ali, A; Alam, S; Bain, T; Wilson, MG |
| Jan-2025 | Rapid evidence profile #88: Approaches to and measures for evaluating interdisciplinary team-based primary care | Goodale, G; Waddell, K; Kupinski, H; Bhuiya, AR; DeMaio, P; Dass, R; Ali, A; Wilson, MG |
| Mar-2025 | Rapid evidence profile #91: Identifying first-case response plans for clade I mpox | Bain, T; Dass, R; Mishra, S; Bhuiya, AR; Grewal, E; Phelps, A; Cura, J; Ali, A; Sivanesanathan, T; Wilson, MG |
| Dec-2022 | Rapid evidence profile 38: What is known from the best-available evidence and from the experiences of other jurisdictions about the frameworks available and interventions used to ensure health professionals and caregivers practise in environments that are physically, psychologically and culturally safe? | Bain, T; Bhuiya, AR; Alam, S; DeMaio, P; Sharma, K; Khan, Z; Wang, A; El-Kadi, A; Moat, KA |
| Apr-2025 | Rapid evidence profile report #94: Examining the potential causal relationship between post-traumatic stress disorder (PTSD) and Parkinson’s disease | Wu, N; Wang, Q; Bain, T; DeMaio, P; Whitelaw, H; Ciurea, P; Ali, A; Bhuiya, AR; Sivanesanathan, T; Wilson, MG |
| Mar-2025 | Rapid evidence synthesis 127: Efficacy and effectiveness of respiratory syncytial virus vaccines and monoclonal antibodies against lower respiratory tract disease in older adults and infants | Wu, N; Phelps, A; Bhuiya, AR; Sivanesanathan, T; Dass, R; Whitelaw, H; Wang, Q; Wilson, MG |
| Sep-2016 | Rapid Synthesis: Addressing Long-term Stays in Hospital for People with Mental Health and Addictions Concerns | Bhuiya, AR; Wilson, MG |
| Oct-2023 | Rapid synthesis: Approaches to support transitions into and out of cancer care systems for patients who do not have a primary-care provider | DeMaio, P; Waddell, K; Bain, T; Alam, S; Dass, R; Cura, J; Ali, A; Bhuiya, AR; Wilson, MG |
| Mar-2024 | Rapid synthesis: Assessing the effectiveness of organizations that support the spread and scale of health- and social-system innovations | Bhuiya, AR; Waddell, K; Moat, KA |
| Aug-2023 | Rapid synthesis: Educational strategies to support optimal prescribing practices by pharmacists | Bhuiya, AR; Bain, T; Dass, R; DeMaio, P; Chen, K; Khan, Z; Wilson, MG |
| Mar-2023 | Rapid synthesis: Ensuring appropriate use of laboratory tests | Waddell, K; DeMaio, P; Bhuiya, AR; Alam, S; Wilson, MG |
| Jun-2021 | Rapid synthesis: Establishing supports for evidence-informed health-system transformation in Nova Scotia | Moat, KA; Bhuiya, AR; Voorheis, Paula |
